MEA Summary Review: The search for biomarkers in ME/CFS using Raman spectroscopy | 06 September 2018

September 6, 2018


 


Charlotte Stephens, ME Association, 06 September, 2018.

This is a new pilot study funded by the ME Association Ramsay Research Fund that introduced a relatively new technique and provided for some intriguing results.

 

 “It is becoming clear that metabolic/energetic dysfunction plays a role in ME/CFS. More information is required to determine if these differences are driving the illness or are a consequence of having ME/CFS.

“Single Cell Raman Spectroscopy is an exciting new tool which can give a readout on aspects of intracellular metabolism. Live cells/tissue are not required, which if the approach is successful, will be a major benefit in developing a diagnostic test.”

Dr Karl Morten

 

About the study

Dr Morten and Prof Wei Huang (Department of Engineering) from Oxford University, attempted to link mitochondrial dysfunction and ME/CFS pathogenesis by comparing the ‘fingerprint’ of a cell model containing no mitochondrial DNA (known as ‘ρ0’) to the ‘fingerprint’ of molecules from the blood cells of ME/CFS patients… (click below to read more).


For more on the amino acid phenylalanine in ME/CFS see also for example:

For more information on the research being conducted by Dr Morten’s team in Oxford (funded by the ME Association Ramsay Research Fund), see:

 

Shopping Basket
Scroll to Top